Organogenesis Holdings Inc.
ORGO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $861 | $4,945 | $15,532 | $94,902 |
| Dep. & Amort. | $17,026 | $23,449 | $10,728 | $16,676 |
| Deferred Tax | -$10,719 | $2,012 | $1,980 | -$31,976 |
| Stock-Based Comp. | $10,578 | $8,996 | $6,552 | $3,864 |
| Change in WC | -$48,889 | -$18,073 | -$34,082 | -$39,288 |
| Other Non-Cash | $45,351 | $9,588 | $24,149 | $17,800 |
| Operating Cash Flow | $14,208 | $30,917 | $24,859 | $61,978 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,032 | -$24,364 | -$33,898 | -$31,220 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$10,032 | -$24,364 | -$33,898 | -$31,220 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$67,644 | -$5,173 | -$3,013 | -$2,014 |
| Stock Issued | $0 | $0 | $0 | $2,198 |
| Stock Repurch. | -$25,479 | $0 | $0 | $0 |
| Dividends Paid | -$1,798 | $0 | $0 | $0 |
| Other Fin. Act. | $122,558 | -$332 | $814 | -$1,220 |
| Financing Cash Flow | $27,637 | -$5,505 | -$2,199 | -$1,036 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $31,813 | $1,048 | -$11,238 | $29,722 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $104,338 | $103,290 | $114,528 | $84,806 |
| End Cash | $136,151 | $104,338 | $103,290 | $114,528 |
| Free Cash Flow | $4,176 | $6,553 | -$9,039 | $30,758 |